User profiles for Syuichi Koarada

Syuichi Koarada

Saga University
Verified email at cc.saga-u.ac.jp
Cited by 2469

Retinal disease in patients with systemic lupus erythematosus

O Ushiyama, K Ushiyama, S Koarada, Y Tada… - Annals of the …, 2000 - ard.bmj.com
OBJECTIVE To investigate the incidence of retinopathy in systemic lupus erythematosus (SLE)
and to clarify its significance in relation to other clinical manifestations. METHODS A …

Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain

S Koarada, Y Wu, N Fertig, DA Sass… - The Journal of …, 2004 - journals.aai.org
At least 20 insulin-dependent diabetes (Idd) loci modify the progression of autoimmune
diabetes in the NOD mouse, an animal model of human type 1 diabetes. The NOD. c3c4 …

Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice

Y Tada, S Kondo, S Aoki, S Koarada… - Arthritis & …, 2011 - Wiley Online Library
Objective Interferon regulatory factor 5 (IRF‐5) is a transcription factor that mediates intracellular
signals activated by engagement of Toll‐like receptors (TLRs). IRF5 polymorphisms are …

[HTML][HTML] Phenotyping of P105-negative B cell subsets in patients with systemic lupus erythematosus

S Koarada, Y Tada, R Suematsu, S Soejima… - Journal of Immunology …, 2012 - hindawi.com
This study aimed to investigate phenotype of RP105(−) B cell subsets in patients with systemic
lupus erythematosus (SLE). Flow cytometry was used for phenotyping RP105-negaive B …

Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan

…, S Takei, S Soejima, H Inoue, S Koarada… - Modern …, 2012 - academic.oup.com
Objective The efficacy of biologics in treating adult Still’s disease (ASD) is suggested, but
the information is still lacking and the validation is insufficient. To determine the efficacy of …

Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma.

…, Y Haruda, O Ushiyama, S Koarada… - The Journal of …, 2003 - jrheum.org
OBJECTIVE: To examine the frequency of depressive symptoms and also to identify factors
closely associated with their development in patients with scleroderma (systemic sclerosis, …

Clinical features of elderly-onset adult-onset Still's disease

…, T Ota, Y Chifu, S Inokuchi, S Koarada… - Modern …, 2021 - academic.oup.com
Objectives To clarify the characteristics of patients with elderly-onset Adult-onset Still’s disease
(AOSD). Methods Patients were classified into elderly-onset (>60 years: 47 patients) and …

The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients

…, A Maruyama, M Sakai, Y Sadanaga, S Koarada… - …, 2019 - academic.oup.com
Objective Based on the antibody profiles of inflammatory myositis patients, we investigated
the type 1 IFN (T1-IFN) signature in serum and DM skin to determine the relationship …

B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus

S Koarada, Y Tada, O Ushiyama… - … : Official Journal of …, 1999 - Wiley Online Library
Objective RP105 is a leucine‐rich repeat (LRR) protein found on all mature mouse B cells.
Its function is poorly defined, although it has been suggested that RP105 activates B cells to …

Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice

…, K Nagasawa, A Ho, F Morito, S Koarada… - The Journal of …, 1999 - journals.aai.org
MRL/Mpj-lpr/lpr (MRL/lpr) mice develop autoimmune disorders, including lymphoproliferation,
glomerulonephritis, autoantibody production, and hypergammaglobulinemia. To …